In
recent years, scientists have identified part of the cascade of
events within the body that leads to the innate immunity response.
When bacterial DNA is released from invading bacteria which enter
the host, it stimulates an enzyme complex called IKK, which activates
a transcription factor (or molecular switch) called NF-kB, leading
to activation of macrophages which attack the invading bacteria.
What was not known was the molecular link, or additional molecules
involved in the process between the bacterial invasion and the
NF-kB activation.
The
UCSD team speculated that the intracellular enzyme DNA-PK might
be involved in the process. DNA-PK is located in both the nucleus
of the cell and in the cytoplasm, the cellular area between the
cell membrane and nucleus. It was known that DNA-PK's role in
the nucleus was to repair DNA double-stranded breaks created by
radiation (x-rays, gamma rays, etc.) or by intrinsic cellular
processes. However,the cytoplasmic functions of DNA-PK were unclear.
Over
a five-year period, the UCSD team studied normal mice and mice
bred without DNA-PK. In order to stimulate the immunity response
in the mice, the researchers used bacterial DNA and a synthetic
oligonucleotide (ODN), a short segment of the bacterial DNA which
has immunostimulatory (ISS) properties. Called ISS-ODN, the synthetic
DNA segment was developed several years ago by Raz and his UCSD
colleagues. Both natural bacterial DNA and the synthetic ISS-ODN
lead to the activation of NF-kB in the normal mice, but not in
the DNA-PK deficient mice. Additional tests using chemical inhibiting
agents also verified the role of DNA-PK in the innate immune response
to bacterial DNA or ISS-ODN.
In
their Cell paper, the researchers also discuss the location
of the molecular pathway that includes DNA-PK. They note that
bacterial DNA and ISS-ODN activate DNA-PK within the cell, rather
than on the cell surface.
Additional
authors of the Cell paper are Wen-Ming Chu, Xing Gong,
Kenji Takabayashi and Augusto Lois, who, along with Raz, are members
of the UCSD Department of Medicine and the UCSD Sam and Rose Stein
Institute for Research on Aging; Michael Karin, Zhi-Wei Li and
Yi Chen, Laboratory of Signal Transduction and Gene Regulation,
UCSD Department of Pharmacology; Hong-Hai Ouyang and Gloria C.
Li, Departments of Radiation Oncology and Medical Physics, Memorial
Sloan-Kettering Cancer Center, New York; and David J. Chen, Life
Science Division, Lawrence Berkeley National Laboratory, Berkeley,
CA.
The
research was supported in part by grants from Dynavax Technologies
Corporation, the National Institutes of Health, tobacco-related
disease research programs, and the California Cancer Research
program.
Note:
The
original story on the body's immunity response is on the UCSD
Health Science News website, www.health.ucsd.edu.
Comment:
We are publishing this on immunity response to aid in our
understanding of how the immune system works. Sally Robertson
Back to Immune
System Boosting Research